Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...
Eli Lilly & Co. (LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026. CEO Dave Ricks ...
Women with painful reproductive conditions say they are being pushed to take hormonal contraceptives which have damaged their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback